Global Tuberculosis Vaccination Market Research Report 2024

Report ID: 1871019 | Published Date: Jan 2025 | No. of Page: 93 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Tuberculosis Vaccination Market Overview
    1.1 Product Overview and Scope of Tuberculosis Vaccination
    1.2 Tuberculosis Vaccination Segment by Type
        1.2.1 Global Tuberculosis Vaccination Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Immune Vaccine
        1.2.3 Therapy Vaccine
    1.3 Tuberculosis Vaccination Segment by Application
        1.3.1 Global Tuberculosis Vaccination Sales Comparison by Application: (2022-2028)
        1.3.2 Self-Procurement
        1.3.3 UNICEF
        1.3.4 Other
    1.4 Global Tuberculosis Vaccination Market Size Estimates and Forecasts
        1.4.1 Global Tuberculosis Vaccination Revenue 2017-2028
        1.4.2 Global Tuberculosis Vaccination Sales 2017-2028
        1.4.3 Tuberculosis Vaccination Market Size by Region: 2017 Versus 2021 Versus 2028
2 Tuberculosis Vaccination Market Competition by Manufacturers
    2.1 Global Tuberculosis Vaccination Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Tuberculosis Vaccination Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Tuberculosis Vaccination Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Tuberculosis Vaccination Manufacturing Sites, Area Served, Product Type
    2.5 Tuberculosis Vaccination Market Competitive Situation and Trends
        2.5.1 Tuberculosis Vaccination Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Tuberculosis Vaccination Players Market Share by Revenue
        2.5.3 Global Tuberculosis Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Tuberculosis Vaccination Retrospective Market Scenario by Region
    3.1 Global Tuberculosis Vaccination Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Tuberculosis Vaccination Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Tuberculosis Vaccination Market Facts & Figures by Country
        3.3.1 North America Tuberculosis Vaccination Sales by Country
        3.3.2 North America Tuberculosis Vaccination Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Tuberculosis Vaccination Market Facts & Figures by Country
        3.4.1 Europe Tuberculosis Vaccination Sales by Country
        3.4.2 Europe Tuberculosis Vaccination Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Tuberculosis Vaccination Market Facts & Figures by Region
        3.5.1 Asia Pacific Tuberculosis Vaccination Sales by Region
        3.5.2 Asia Pacific Tuberculosis Vaccination Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Tuberculosis Vaccination Market Facts & Figures by Country
        3.6.1 Latin America Tuberculosis Vaccination Sales by Country
        3.6.2 Latin America Tuberculosis Vaccination Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Tuberculosis Vaccination Market Facts & Figures by Country
        3.7.1 Middle East and Africa Tuberculosis Vaccination Sales by Country
        3.7.2 Middle East and Africa Tuberculosis Vaccination Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Tuberculosis Vaccination Historic Market Analysis by Type
    4.1 Global Tuberculosis Vaccination Sales Market Share by Type (2017-2022)
    4.2 Global Tuberculosis Vaccination Revenue Market Share by Type (2017-2022)
    4.3 Global Tuberculosis Vaccination Price by Type (2017-2022)
5 Global Tuberculosis Vaccination Historic Market Analysis by Application
    5.1 Global Tuberculosis Vaccination Sales Market Share by Application (2017-2022)
    5.2 Global Tuberculosis Vaccination Revenue Market Share by Application (2017-2022)
    5.3 Global Tuberculosis Vaccination Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Merck
        6.1.1 Merck Corporation Information
        6.1.2 Merck Description and Business Overview
        6.1.3 Merck Tuberculosis Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Merck Tuberculosis Vaccination Product Portfolio
        6.1.5 Merck Recent Developments/Updates
    6.2 Japan BCG Lab
        6.2.1 Japan BCG Lab Corporation Information
        6.2.2 Japan BCG Lab Description and Business Overview
        6.2.3 Japan BCG Lab Tuberculosis Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Japan BCG Lab Tuberculosis Vaccination Product Portfolio
        6.2.5 Japan BCG Lab Recent Developments/Updates
    6.3 Serum Institute of India
        6.3.1 Serum Institute of India Corporation Information
        6.3.2 Serum Institute of India Description and Business Overview
        6.3.3 Serum Institute of India Tuberculosis Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Serum Institute of India Tuberculosis Vaccination Product Portfolio
        6.3.5 Serum Institute of India Recent Developments/Updates
    6.4 AJ Vaccines
        6.4.1 AJ Vaccines Corporation Information
        6.4.2 AJ Vaccines Description and Business Overview
        6.4.3 AJ Vaccines Tuberculosis Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 AJ Vaccines Tuberculosis Vaccination Product Portfolio
        6.4.5 AJ Vaccines Recent Developments/Updates
    6.5 BioFarma
        6.5.1 BioFarma Corporation Information
        6.5.2 BioFarma Description and Business Overview
        6.5.3 BioFarma Tuberculosis Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 BioFarma Tuberculosis Vaccination Product Portfolio
        6.5.5 BioFarma Recent Developments/Updates
    6.6 GreenSignal Bio Pharma
        6.6.1 GreenSignal Bio Pharma Corporation Information
        6.6.2 GreenSignal Bio Pharma Description and Business Overview
        6.6.3 GreenSignal Bio Pharma Tuberculosis Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 GreenSignal Bio Pharma Tuberculosis Vaccination Product Portfolio
        6.6.5 GreenSignal Bio Pharma Recent Developments/Updates
    6.7 China National Biotec
        6.6.1 China National Biotec Corporation Information
        6.6.2 China National Biotec Description and Business Overview
        6.6.3 China National Biotec Tuberculosis Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 China National Biotec Tuberculosis Vaccination Product Portfolio
        6.7.5 China National Biotec Recent Developments/Updates
    6.8 Biomed Lublin
        6.8.1 Biomed Lublin Corporation Information
        6.8.2 Biomed Lublin Description and Business Overview
        6.8.3 Biomed Lublin Tuberculosis Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Biomed Lublin Tuberculosis Vaccination Product Portfolio
        6.8.5 Biomed Lublin Recent Developments/Updates
    6.9 Taj Pharmaceuticals
        6.9.1 Taj Pharmaceuticals Corporation Information
        6.9.2 Taj Pharmaceuticals Description and Business Overview
        6.9.3 Taj Pharmaceuticals Tuberculosis Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Taj Pharmaceuticals Tuberculosis Vaccination Product Portfolio
        6.9.5 Taj Pharmaceuticals Recent Developments/Updates
    6.10 Ataulpho de Paiva
        6.10.1 Ataulpho de Paiva Corporation Information
        6.10.2 Ataulpho de Paiva Description and Business Overview
        6.10.3 Ataulpho de Paiva Tuberculosis Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Ataulpho de Paiva Tuberculosis Vaccination Product Portfolio
        6.10.5 Ataulpho de Paiva Recent Developments/Updates
    6.11 IVAC – Institute of Vaccines and Medical Biologicals
        6.11.1 IVAC – Institute of Vaccines and Medical Biologicals Corporation Information
        6.11.2 IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Description and Business Overview
        6.11.3 IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Product Portfolio
        6.11.5 IVAC – Institute of Vaccines and Medical Biologicals Recent Developments/Updates
    6.12 Queen Saovabha Mem. Inst
        6.12.1 Queen Saovabha Mem. Inst Corporation Information
        6.12.2 Queen Saovabha Mem. Inst Tuberculosis Vaccination Description and Business Overview
        6.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Queen Saovabha Mem. Inst Tuberculosis Vaccination Product Portfolio
        6.12.5 Queen Saovabha Mem. Inst Recent Developments/Updates
    6.13 Microgen
        6.13.1 Microgen Corporation Information
        6.13.2 Microgen Tuberculosis Vaccination Description and Business Overview
        6.13.3 Microgen Tuberculosis Vaccination Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Microgen Tuberculosis Vaccination Product Portfolio
        6.13.5 Microgen Recent Developments/Updates
7 Tuberculosis Vaccination Manufacturing Cost Analysis
    7.1 Tuberculosis Vaccination Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Tuberculosis Vaccination
    7.4 Tuberculosis Vaccination Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Tuberculosis Vaccination Distributors List
    8.3 Tuberculosis Vaccination Customers
9 Tuberculosis Vaccination Market Dynamics
    9.1 Tuberculosis Vaccination Industry Trends
    9.2 Tuberculosis Vaccination Market Drivers
    9.3 Tuberculosis Vaccination Market Challenges
    9.4 Tuberculosis Vaccination Market Restraints
10 Global Market Forecast
    10.1 Tuberculosis Vaccination Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Tuberculosis Vaccination by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Tuberculosis Vaccination by Type (2023-2028)
    10.2 Tuberculosis Vaccination Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Tuberculosis Vaccination by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Tuberculosis Vaccination by Application (2023-2028)
    10.3 Tuberculosis Vaccination Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Tuberculosis Vaccination by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Tuberculosis Vaccination by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Tuberculosis Vaccination Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million)
    Table 2. Global Tuberculosis Vaccination Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million)
    Table 3. Global Tuberculosis Vaccination Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Tuberculosis Vaccination Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Tuberculosis Vaccination Sales (Units) of Key Manufacturers (2017-2022)
    Table 6. Global Tuberculosis Vaccination Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Tuberculosis Vaccination Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Tuberculosis Vaccination Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Tuberculosis Vaccination Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Tuberculosis Vaccination Manufacturing Sites and Area Served
    Table 11. Manufacturers Tuberculosis Vaccination Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Tuberculosis Vaccination by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Vaccination as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Tuberculosis Vaccination Sales by Region (2017-2022) & (Units)
    Table 16. Global Tuberculosis Vaccination Sales Market Share by Region (2017-2022)
    Table 17. Global Tuberculosis Vaccination Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Tuberculosis Vaccination Revenue Market Share by Region (2017-2022)
    Table 19. North America Tuberculosis Vaccination Sales by Country (2017-2022) & (Units)
    Table 20. North America Tuberculosis Vaccination Sales Market Share by Country (2017-2022)
    Table 21. North America Tuberculosis Vaccination Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Tuberculosis Vaccination Revenue Market Share by Country (2017-2022)
    Table 23. Europe Tuberculosis Vaccination Sales by Country (2017-2022) & (Units)
    Table 24. Europe Tuberculosis Vaccination Sales Market Share by Country (2017-2022)
    Table 25. Europe Tuberculosis Vaccination Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Tuberculosis Vaccination Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Tuberculosis Vaccination Sales by Region (2017-2022) & (Units)
    Table 28. Asia Pacific Tuberculosis Vaccination Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Tuberculosis Vaccination Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Tuberculosis Vaccination Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Tuberculosis Vaccination Sales by Country (2017-2022) & (Units)
    Table 32. Latin America Tuberculosis Vaccination Sales Market Share by Country (2017-2022)
    Table 33. Latin America Tuberculosis Vaccination Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Tuberculosis Vaccination Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Tuberculosis Vaccination Sales by Country (2017-2022) & (Units)
    Table 36. Middle East and Africa Tuberculosis Vaccination Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Tuberculosis Vaccination Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Tuberculosis Vaccination Revenue Market Share by Country (2017-2022)
    Table 39. Global Tuberculosis Vaccination Sales by Type (2017-2022) & (Units)
    Table 40. Global Tuberculosis Vaccination Sales Market Share by Type (2017-2022)
    Table 41. Global Tuberculosis Vaccination Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Tuberculosis Vaccination Revenue Share by Type (2017-2022)
    Table 43. Global Tuberculosis Vaccination Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Tuberculosis Vaccination Sales (Units) by Application (2017-2022)
    Table 45. Global Tuberculosis Vaccination Sales Market Share by Application (2017-2022)
    Table 46. Global Tuberculosis Vaccination Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Tuberculosis Vaccination Revenue Share by Application (2017-2022)
    Table 48. Global Tuberculosis Vaccination Price by Application (2017-2022) & (US$/Unit)
    Table 49. Merck Corporation Information
    Table 50. Merck Description and Business Overview
    Table 51. Merck Tuberculosis Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Merck Tuberculosis Vaccination Product
    Table 53. Merck Recent Developments/Updates
    Table 54. Japan BCG Lab Corporation Information
    Table 55. Japan BCG Lab Description and Business Overview
    Table 56. Japan BCG Lab Tuberculosis Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Japan BCG Lab Tuberculosis Vaccination Product
    Table 58. Japan BCG Lab Recent Developments/Updates
    Table 59. Serum Institute of India Corporation Information
    Table 60. Serum Institute of India Description and Business Overview
    Table 61. Serum Institute of India Tuberculosis Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Serum Institute of India Tuberculosis Vaccination Product
    Table 63. Serum Institute of India Recent Developments/Updates
    Table 64. AJ Vaccines Corporation Information
    Table 65. AJ Vaccines Description and Business Overview
    Table 66. AJ Vaccines Tuberculosis Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. AJ Vaccines Tuberculosis Vaccination Product
    Table 68. AJ Vaccines Recent Developments/Updates
    Table 69. BioFarma Corporation Information
    Table 70. BioFarma Description and Business Overview
    Table 71. BioFarma Tuberculosis Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. BioFarma Tuberculosis Vaccination Product
    Table 73. BioFarma Recent Developments/Updates
    Table 74. GreenSignal Bio Pharma Corporation Information
    Table 75. GreenSignal Bio Pharma Description and Business Overview
    Table 76. GreenSignal Bio Pharma Tuberculosis Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. GreenSignal Bio Pharma Tuberculosis Vaccination Product
    Table 78. GreenSignal Bio Pharma Recent Developments/Updates
    Table 79. China National Biotec Corporation Information
    Table 80. China National Biotec Description and Business Overview
    Table 81. China National Biotec Tuberculosis Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. China National Biotec Tuberculosis Vaccination Product
    Table 83. China National Biotec Recent Developments/Updates
    Table 84. Biomed Lublin Corporation Information
    Table 85. Biomed Lublin Description and Business Overview
    Table 86. Biomed Lublin Tuberculosis Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. Biomed Lublin Tuberculosis Vaccination Product
    Table 88. Biomed Lublin Recent Developments/Updates
    Table 89. Taj Pharmaceuticals Corporation Information
    Table 90. Taj Pharmaceuticals Description and Business Overview
    Table 91. Taj Pharmaceuticals Tuberculosis Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. Taj Pharmaceuticals Tuberculosis Vaccination Product
    Table 93. Taj Pharmaceuticals Recent Developments/Updates
    Table 94. Ataulpho de Paiva Corporation Information
    Table 95. Ataulpho de Paiva Description and Business Overview
    Table 96. Ataulpho de Paiva Tuberculosis Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. Ataulpho de Paiva Tuberculosis Vaccination Product
    Table 98. Ataulpho de Paiva Recent Developments/Updates
    Table 99. IVAC – Institute of Vaccines and Medical Biologicals Corporation Information
    Table 100. IVAC – Institute of Vaccines and Medical Biologicals Description and Business Overview
    Table 101. IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. IVAC – Institute of Vaccines and Medical Biologicals Tuberculosis Vaccination Product
    Table 103. IVAC – Institute of Vaccines and Medical Biologicals Recent Developments/Updates
    Table 104. Queen Saovabha Mem. Inst Corporation Information
    Table 105. Queen Saovabha Mem. Inst Description and Business Overview
    Table 106. Queen Saovabha Mem. Inst Tuberculosis Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. Queen Saovabha Mem. Inst Tuberculosis Vaccination Product
    Table 108. Queen Saovabha Mem. Inst Recent Developments/Updates
    Table 109. Microgen Corporation Information
    Table 110. Microgen Description and Business Overview
    Table 111. Microgen Tuberculosis Vaccination Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 112. Microgen Tuberculosis Vaccination Product
    Table 113. Microgen Recent Developments/Updates
    Table 114. Production Base and Market Concentration Rate of Raw Material
    Table 115. Key Suppliers of Raw Materials
    Table 116. Tuberculosis Vaccination Distributors List
    Table 117. Tuberculosis Vaccination Customers List
    Table 118. Tuberculosis Vaccination Market Trends
    Table 119. Tuberculosis Vaccination Market Drivers
    Table 120. Tuberculosis Vaccination Market Challenges
    Table 121. Tuberculosis Vaccination Market Restraints
    Table 122. Global Tuberculosis Vaccination Sales Forecast by Type (2023-2028) & (Units)
    Table 123. Global Tuberculosis Vaccination Sales Market Share Forecast by Type (2023-2028)
    Table 124. Global Tuberculosis Vaccination Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 125. Global Tuberculosis Vaccination Revenue Market Share Forecast by Type (2023-2028)
    Table 126. Global Tuberculosis Vaccination Sales Forecast by Application (2023-2028) & (Units)
    Table 127. Global Tuberculosis Vaccination Sales Market Share Forecast by Application (2023-2028)
    Table 128. Global Tuberculosis Vaccination Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 129. Global Tuberculosis Vaccination Revenue Market Share Forecast by Application (2023-2028)
    Table 130. Global Tuberculosis Vaccination Sales Forecast by Region (2023-2028) & (Units)
    Table 131. Global Tuberculosis Vaccination Sales Market Share Forecast by Region (2023-2028)
    Table 132. Global Tuberculosis Vaccination Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 133. Global Tuberculosis Vaccination Revenue Market Share Forecast by Region (2023-2028)
    Table 134. Research Programs/Design for This Report
    Table 135. Key Data Information from Secondary Sources
    Table 136. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Tuberculosis Vaccination
    Figure 2. Global Tuberculosis Vaccination Market Share by Type in 2021 & 2028
    Figure 3. Immune Vaccine Product Picture
    Figure 4. Therapy Vaccine Product Picture
    Figure 5. Global Tuberculosis Vaccination Market Share by Application in 2021 & 2028
    Figure 6. Self-Procurement
    Figure 7. UNICEF
    Figure 8. Other
    Figure 9. Global Tuberculosis Vaccination Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Tuberculosis Vaccination Market Size (2017-2028) & (US$ Million)
    Figure 11. Global Tuberculosis Vaccination Sales (2017-2028) & (Units)
    Figure 12. Tuberculosis Vaccination Sales Share by Manufacturers in 2021
    Figure 13. Global Tuberculosis Vaccination Revenue Share by Manufacturers in 2021
    Figure 14. The Global 5 and 10 Largest Tuberculosis Vaccination Players: Market Share by Revenue in 2021
    Figure 15. Tuberculosis Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 16. Global Tuberculosis Vaccination Sales Market Share by Region (2017-2022)
    Figure 17. Global Tuberculosis Vaccination Sales Market Share by Region in 2021
    Figure 18. Global Tuberculosis Vaccination Revenue Market Share by Region (2017-2022)
    Figure 19. Global Tuberculosis Vaccination Revenue Market Share by Region in 2021
    Figure 20. United States Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Canada Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Germany Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. France Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. U.K. Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Italy Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Russia Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. China Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Japan Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. South Korea Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. India Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Australia Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. China Taiwan Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Indonesia Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Thailand Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Malaysia Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Mexico Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Brazil Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Argentina Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Turkey Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Saudi Arabia Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. UAE Tuberculosis Vaccination Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Sales Market Share of Tuberculosis Vaccination by Type (2017-2022)
    Figure 43. Manufacturing Cost Structure of Tuberculosis Vaccination
    Figure 44. Manufacturing Process Analysis of Tuberculosis Vaccination
    Figure 45. Tuberculosis Vaccination Industrial Chain Analysis
    Figure 46. Channels of Distribution
    Figure 47. Distributors Profiles
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Japan BCG Lab
Serum Institute of India
AJ Vaccines
BioFarma
GreenSignal Bio Pharma
China National Biotec
Biomed Lublin
Taj Pharmaceuticals
Ataulpho de Paiva
IVAC – Institute of Vaccines and Medical Biologicals
Queen Saovabha Mem. Inst
Microgen
Frequently Asked Questions
Tuberculosis Vaccination report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Tuberculosis Vaccination report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Tuberculosis Vaccination report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

BCG Vaccination

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More